The Akt and mitogen-activated protein kinase (MAPK) pathways have been implicated in tumor cell survival and contribute to radiation resistance. However, the molecular basis for link between MAPK and Akt in cell survival response to radiation is unclear. Here, we show that c-Src-Rac1-p38 MAPK pathway signals Akt activation and cell survival in response to radiation. 
Introduction
Sensitivity of tumor cells to radiation is a critical determinant of the probability of local control and ultimately of cure of cancers by radiation therapy. It has been shown that many factors affect susceptibility of tumor cells to ionizing radiation. Among them, intracellular signaling molecules seem to play an important role in determining the intrinsic radiosensitivity of tumor cells. Indeed, exposure of cells to ionizing radiation results in the simultaneous activation or down-regulation of multiple signaling pathways, which play critical roles in cell type-specific control of survival or death in response to ionizing radiation (1) (2) (3) (4) .
The serine-threonine kinase Akt plays a pivotal role in fundamental cellular functions, such as proliferation, migration, and survival, by phosphorylating various substrates, including Bad, IKK, Raf, mammalian target of rapamycin, and caspase-9 (5, 6). Moreover, Akt not only is cell survival kinase but also plays a central role in promoting tumorigenesis (7, 8) . Overexpression of Akt is reported in several human cancers, including breast, colon, ovarian, prostate, and pancreas (9) . Full activation of Akt requires multiple steps mediated by phosphoinositide 3-kinase (PI3K) and 3-phosphoinositidedependent protein kinase (PDK) 1. Activation of the lipid kinase, PI3K, leads to generation of the second messenger, phosphatidylinositol-3,4,5-triphosphate, and subsequent recruitment of Akt to the plasma membrane. Membrane-bound PDK1 phosphorylates Thr 308 in the pleckstrin homology domain of Akt, resulting in activation. Next, Ser 473 is phosphorylated at the COOH-terminal domain for full activation of Akt by either autophosphorylation or an uncharacterized kinase, PDK2 (10, 11) .
p38 mitogen-activated protein kinase (MAPK) responds strongly to a variety of stress signals including tumor necrosis factor, ionizing and UV irradiation, interleukin-1, chemotherapeutic drugs, and hyperosmotic stress (12) (13) (14) (15) (16) (17) (18) (19) . Indeed, activation of p38 MAPK has been shown to correlate well with the apoptotic cell death induced by these stress stimuli. In contrast, recent observations showed that p38 MAPK is a critical regulator for the cell survival and proliferation in response to cisplatin, doxorubicin, camptothecin, UV irradiation, and repetitive low-grade oxidative stress (20) (21) (22) . Furthermore, other reports showed that p38 MAPK signaling is essentially required for the maintenance of a transformed cell phenotype in human malignancy (23, 24) . These results are consistent with the fact that p38 MAPK pathway is involved in Akt activation as a survival response in human neutrophils (25) and that Akt phosphorylation elicited by angiotensin II is mediated by p38 MAPK signaling pathway (26) .
Many reports showed that radiation-mediated activation of Akt signaling is an important mechanism in resistance of tumor cells to irradiation. Moreover, other reports also showed that MAPK pathway plays a role in cell survival against radiation-induced cell death. In the present study, we investigated the molecular basis for link between MAPK and Akt in cell survival in response to radiation. We show that the c-Src-Rac1-p38 MAPK pathway is required for the Akt activation in response to radiation and that the pathway plays a cytoprotective role against radiation-induced cell death. Improved understanding of the mechanisms involved in survival in response to radiation may ultimately afford novel strategies of intervention in specific pathways to favorably alter the therapeutic efficacy of human malignancy treatments.
Results

Ionizing Radiation Triggers Phosphorylation of Akt as a Cell Survival Response to Radiation
Considerable evidence shows that the PI3K-Akt pathway enhances cell survival in response to various cellular stress conditions. We investigated whether the PI3K-Akt pathway is activated and involved in cervical cancer cell survival in response to radiation. Because full activation of Akt requires phosphorylation at two sites, Thr 308 and Ser 473 , immunoblot analysis was conducted with antibodies specific for p-Thr 308 -Akt and p-Ser 473 -Akt in irradiated HeLa cells. Exposure of cells to radiation induced PI3K activation and subsequently increased kinase activity of Akt (Fig. 1A) . Radiation also induced significant phosphorylation of Akt at Thr 308 and Ser
473
( Fig. 1A; Supplementary Fig. S1 ). Moreover, overexpression of dominant-negative form of Akt led to an increase in cell death in response to radiation (Fig. 1B) . In addition, pretreatment with A. Activation of PI3K and Akt in response to radiation. HeLa cells were exposed to 10 Gy g-radiation. After 24, 48, and 72 h, cell lysates were immunoprecipitated with anti-PI3K (anti-p85) or Akt antibody. PI3K assay and Akt kinase assay were done on the immune complexes. A representative autoradiogram of the PI3K assay is shown, and the position of phosphatidylinositol phosphate is indicated. Akt kinase activity was determined by using GST-GSK3-h fusion protein as a substrate. Cell lysates were also subjected to Western blot analysis with anti-Thr 308 -Akt, anti-Ser 473 -Akt, anti-Akt, and anti-h-actin antibodies. h-Actin was used as a loading control. B. Effect of Akt inhibition on radiation-induced cell death. HeLa cells were exposed to 10 Gy g-radiation in the presence or absence of dominant-negative Akt (c-Myc tagged). After 24, 48, and 72 h, cell death was determined by flow cytometric analysis as described in Materials and Methods. Mean F SE of three independent experiments. *, P < 0.05. After 48 h, cell lysates were also subjected to Western blot analysis with anti-c-Myc, anti-cleaved caspase-3, antipoly(ADP-ribose) polymerase, and anti-h-actin antibodies. h-Actin was used as a loading control. C. Effect of the PI3K inhibition on radiation-induced Akt phosphorylation. HeLa cells were exposed to 10 Gy g-radiation in the presence or absence of 10 Amol/L LY294002. After 48 h, cell lysates were immunoprecipitated with anti-Akt antibody, and Akt kinase assay was done on immune complexes. Akt kinase activity was determined by using GST-GSK3-h fusion protein as a substrate. Cell lysates were also subjected to Western blot analysis with anti-Thr 308 -Akt, anti-Ser 473 -Akt, anti-Akt, and anti-h-actin antibodies. h-Actin was used as a loading control. MAPKs are implicated in the regulation of apoptotic cell death in response to various stimuli. To confirm the potential involvement of MAPK in ionizing radiation-induced cell death, we initially measured changes in MAPK activity after radiation treatment. As shown in Fig. 2A and Supplementary Fig. S1 , irradiation of cells led to a dramatic increase in the phosphorylation of p38 MAPK and c-Jun NH 2 -terminal kinase (JNK), but gradual down-regulation of phosphorylated extracellular signal-regulated kinase (ERK). JNK and p38 MAPK phosphorylations were apparent at 24 h and peaked at 48 h after irradiation. The total MAPK cellular levels remained constant. Next, we investigated whether the changes in activities of MAPK are associated with radiation response in various human cervical cancer cells. To determine whether p38 MAPK and/or JNK are involved in radiation response, we employed specific inhibitors of these proteins in experiments with three human cervical cancer cell lines (HeLa, CaSki, and SiHa) and analyzed their effects on cell death in response to radiation. Treatment of SP600125 markedly inhibited radiation-induced cell death, whereas SB203580 effectively enhanced cell death in human cervical cancer cells ( Fig. 2B; Supplementary Fig. S2A ). Our findings indicate that JNK is involved in radiation-induced cell death, whereas p38 MAPK is implicated in cell survival in response to ionizing radiation.
Exposure of cells to radiation induced significant phosphorylation of Akt at Thr 308 and Ser 473 (Fig. 1A) . To further determine whether p38 MAPK and/or JNK are involved in phosphorylation of Akt to radiation response, we employed specific inhibitors of these proteins in experiments with human cervical cancer cells. Inhibition of p38 MAPK by pretreatment with SB203580 completely attenuated Ser 473 phosphorylation of Akt but did not block Thr 308 phosphorylation ( (Fig. 3A) . However, inhibition of p38 MAPK failed to block radiation-induced PI3K and PDK1 activations. Consistent with these results, overexpression of dominant-negative form of p38 MAPK also clearly suppressed increase in kinase activity and phosphorylation at (Fig. 4A) . Expression of RacN17, a dominantnegative form of Rac1, effectively suppressed p38 MAPK activation and Ser 473 phosphorylation of Akt induced by radiation ( Fig. 4B ) but did not alter the Thr 308 phosphorylation. RacN17 also effectively enhanced radiation-induced cell death (Fig. 4C) . These results support the theory that Rac1 acts as an upstream regulator of p38 MAPK in activation of Akt and cell survival in response to radiation.
c-Src Is Involved in Activation of the Cytoprotective Rac1-p38 MAPK-Akt Signaling Pathway
Recent reports show that Src family kinases are associated with MAPK activation in response to genotoxic and oxidative stress (27) (28) (29) . Thus, we investigated whether Src family kinases are involved in the radiation response of human cervical cancer cells. Exposure of cell to ionizing radiation induced selective activation of c-Src but not Lyn or Fyn (Fig. 5A) . Inhibition of c-Src activation by pretreatment of cells with PP2, a Src family kinase inhibitor, decreased radiationinduced Rac1 and p38 MAPK activations (Fig. 5B) . PP2 additionally inhibited Akt phosphorylation at Ser 473 but not Thr 308 in three different human cervical cancer cell lines ( Fig. 5B; Supplementary Fig. S4A ). Consistently, small interfering RNA (siRNA) targeting of c-Src clearly revealed that inhibition of c-Src suppresses radiation-induced p38 MAPK activation and Akt phosphorylation at Ser 473 (Fig. 5C ). Inhibition of c-Src by PP2 or siRNA targeting of c-Src also significantly enhanced radiation-induced cell death in three different human cervical cancer cell lines ( Fig. 5D ; Supplementary Fig. S4B ). These data imply that c-Src is necessary for stimulation of the Rac1-p38 MAPK-Akt signaling pathway and cell survival response against radiation-induced cell death in human cervical cancer cells.
Discussion
Intracellular signaling molecules and survival factors play important roles in determining the radiation response of tumor cells. The Akt signaling and the MAPK pathway have been implicated in tumor cell survival and contribute to radiation resistance (7, 8, 19) . In this investigation, we elucidate the molecular basis for link between MAPK and Akt in cell survival response to radiation. Our data show that the c-SrcRac1-p38 MAPK pathway plays a cytoprotective role in response to radiation through activation of Akt.
It has been known that PI3K activates Akt, which in turn triggers cytoprotective events through Bad phosphorylation and nuclear factor-nB activation (17) . Concomitantly, we observed that radiation triggers PI3K-dependent activation of Akt in response to radiation treatment. Moreover, inhibition of Akt enhanced radiation-induced apoptotic cell death, suggesting that activation of Akt plays a cytoprotective role against cell death. Membrane-bound PDK1 phosphorylates Thr 308 in the pleckstrin homology domain of Akt, resulting in activation (10, 11 It is well established that the Rac1/p38 MAPK pathway is activated by various types of membrane-associated cellular signals (33, 34) . We provided further evidence that Rac1 is involved in p38 MAPK activation and cell survival in response to radiation. Inhibition of Rac1 activity with RacN17 attenuated p38 MAPK activation and Ser 473 phosphorylation of Akt and significantly enhanced cell death, suggesting that Rac1 acts as an upstream regulator of p38 MAPK in cell survival response to ionizing radiation.
We further show that c-Src is essential for the activations of Rac1, p38 MAPK, and Ser 473 phosphorylation of Akt in human cervical cancer cells. Our data clearly show that c-Src kinase, but not Lyn or Fyn, is selectively activated in response to radiation and that inhibition of c-Src leads to suppression of Rac1-p38 MAPK signaling and Ser 473 phosphorylation of Akt and also leads to enhanced apoptotic cell death. These findings are consistent with recent reports that activation of c-Src in response to genotoxic and oxidative stress is associated with stimulation of protein kinase C and MAPK activity (27) (28) (29) . However, we failed to find any changes in protein kinase C activities in response to radiation, and inhibition of c-Src did not show any additional effects on protein kinase C activities (data not shown). Based on these findings, we conclude that c-Src kinase is associated with activation of Rac1-p38 MAPK-Akt signaling pathway in cell survival response to radiation.
In summary, we show here that the c-Src-Rac1-p38 MAPK pathway is required for activation of Akt in response to radiation and that the pathway plays an important role in cell survival against radiation-induced cell death. Elucidation of the molecular mechanisms of cell survival response to radiation may ultimately afford novel strategies of intervention in specific 
Materials and Methods
Materials
Polyclonal antibodies to p-ERK, p38 MAPK (a), Akt, PTEN, Src, Fyn, Lyn, and myc were purchased from Santa Cruz Biotechnology. h-Actin, Flag, L-a-phosphatidylinositol, and enolase were purchased from Sigma. Polyclonal antibodies to ERK, JNK, p-p38 MAPK, p-JNK, p-Akt, poly(ADP-ribose) polymerase, and cleaved caspase-3 were obtained from Cell Signaling Technology. Polyclonal antibodies to p85, glutathione S-transferase (GST)-Akt protein, GST-glycogen synthase kinase 3-h (GSK3-h) fusion protein, and Pak-conjugated agarose were purchased from Upstate Biotechnology. The MEK inhibitor (PD98059), p38 MAPK inhibitor (SB203580), JNK inhibitor (SP600125), Src family kinase inhibitor (PP2), and PI3K inhibitor (LY294002) were obtained from Calbiochem.
Cell Culture and Transfection
Human cervical carcinoma cell lines (HeLa, CaSki, and SiHa) were obtained from the American Type Culture MAPK on radiation-induced Akt phosphorylation. HeLa cells were exposed to 10 Gy g-radiation in the presence or absence of wild-type p38 MAPK. After 48 h, cell lysates were subjected to Western blot analysis with anti-Thr 308 -Akt, anti-Ser
473
-Akt, anti-Akt, anti-Flag, and anti-h-actin antibodies. h-Actin was used as a loading control. Cell lysates were also immunoprecipitated with anti-Ser 473 -Akt antibody, and Akt kinase assay was done on immune complexes. GST-GSK3-h fusion protein was used as substrates for Akt.
Collection. HeLa and CaSki cells were grown in RPMI 1640 supplemented with 10% fetal bovine serum, whereas SiHa cells were cultured in MEM supplemented with 10% fetal bovine serum and nonessential amino acids. Media were supplemented with 100 units/mL penicillin and 100 Ag/mL streptomycin, and all cells were incubated at 37jC in 5% CO 2 . Cells were transfected with the expression vector of pUSE-dominant-negative Akt, pCMV5-Flag-p38 MAPK, pCMV5-Flag-dominant-negative p38 MAPK (KM), dominant-negative Rac1 (RacN17), or control vector using Lipofectamine PLUS reagent (Invitrogen) according to the manufacturer's recommendations. Cells were analyzed 24 h after transfection.
siRNA Transfection
RNA interference of c-Src was done using 21-bp (including a 2-deoxynucleotide overhang) siRNA duplexes purchased from Ambion. A control siRNA specific for green fluorescent protein (CCACTACCTGAGCACCCAG) was used as the negative control. Cells were plated on 100 mm dishes at 50% confluency, and siRNA duplexes (50 nmol/L) were introduced into cells using Lipofectamine 2000 (Invitrogen) by following the procedure recommended by the manufacturer.
Quantification of Cell Death
Fluorescence-activated cell sorting analysis using propidium iodide staining detects cell death by means of the dye entering the cells along with changes in the target cell membrane and DNA damage. For the cell death assessment, the cells were plated in 60 mm dish with cell density of 2 Â 10 5 per dish and treated with radiation the next day. At indicated time points, cells were harvested by trypsinization, washed in PBS, and then incubated in propidium iodide (2.5 Ag/mL) for 5 min at room temperature. Then, cells (10,000 per sample) were analyzed on a FACSscan flow cytometer using Cell Quest software.
Irradiation
Cells were plated in 35, 60, or 100 mm dishes and incubated at 37jC under humidified 5% CO 2 -95% air in culture medium until 70% to 80% confluent. Cells were then exposed to g-rays with 137 Cs g-ray source (Atomic Energy of Canada) with a dose rate of 3.81 Gy/min.
Western Blot Analysis
Western blot analysis was done as described previously (35) . Briefly, cell lysates were prepared by extracting proteins with lysis buffer [40 mmol/L Tris-HCl (pH 8.0), 120 mmol/L NaCl, 0.1% NP-40] supplemented with protease inhibitors. Proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked with 5% nonfat dry milk in TBS and incubated with primary antibodies for 1 h at room temperature. Blots were developed with a peroxidase-conjugated secondary antibody, and proteins were visualized by enhanced chemiluminescence procedures (Amersham) using the manufacturer's protocol. In addition, the enzyme activity of Src family that phosphorylates tyrosine residues of target proteins was monitored by supplementing an exogenous substrate, enolase (0.125 mg/mL; Sigma), to the reaction mixture. Proteins were separated on SDS-polyacrylamide gels, and bands were detected by autoradiography.
PI3K Assay
Cells were lysed in 20 mmol/LTris-HCl (pH 8.0), 137 mmol/L NaCl, 1 mmol/L MgCl 2 , 1 mmol/L CaCl 2 , 1% NP-40, 10% glycerol, 2 mmol/L sodium orthovanadate, 10 Ag/mL aprotinin, 10 Ag/mL leupeptin, and 1 mmol/L phenylmethylsulfonyl fluoride. Lysates were clarified, and equal amounts of the lysate proteins (400 Ag) were immunoprecipitated with an antibody against the p85 subunit of PI3K (Upstate Biotechnology). Immune complexes were washed twice with 1% NP-40, 1 mmol/L sodium orthovanadate, and PBS (pH 7. 
Rac1 Activation Assay
Rac1 activation assays were conducted as described previously (36) . Cells lysates were prepared by total extracting proteins with lysis buffer [40 mmol/L Tris-HCl (pH 8.0), 120 mmol/L NaCl, 0.1% NP-40] supplemented with protease inhibitors. The cell lysates were used immediately for a pulldown of activated Rac with Pak1-agarose-beads. Pak1-agarosebeads were added to 500 AL cell lysate, and the samples were rotated at 4jC for 60 min. The agarose beads were collected by spinning at 14,000 rpm for 5 s, and the supernatants were removed. The beads were washed three times and suspended in SDS buffer for Rac detection by Western blot.
Statistical Analysis
Statistical analyses were done using Student's t test. The data were expressed as mean F SE derived from at least three independent experiments. Differences were considered significant at P < 0.05.
